Facebook
X
LinkedIn
ForwardSex, Drugs and Radiomics of Brain Cancer
Learning Objectives:
- Demonstrate the integrative role of biological sex-differences in glioma.
- Quantify heterogeneity in drug delivery in glioma.
- Demonstrate the role of radiomics in revealing intra-tumoral molecular diversity.
Kristin Rae Swanson, PhD
Co-Director, Precision NeuroTherapeutics Innovation Program - Mayo Clinic
Director, Mathematical Neuro-Oncology Lab - Mayo Clinic
Professor and Vice Chair (Research, Neurosurgery - Mayo Clinic
Professor, Mathematical and Statistical Sciences - Arizona State University
LOCATION Virtual Only, via Zoom
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
ABOUT Cancer Center Grand Rounds are held weekly on Thursdays for faculty and junior faculty, investigators and junior investigators, scholars, graduate students, medical students, research fellows, administration and allied health staff.
CREDIT STATEMENT(S) In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medicine Education (ACCME) the Accreditation Council of Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCCP) to provide continuing education for the healthcare team.
ARCHIVED PRESENTATIONS Located in Arizona Cancer Center Grand Rounds Video Library
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.